Negative symptoms or catatonia?
Dhossche
D
D
Petrides
G
G
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use; D002648:Child; D000078306:Clobazam; D003024:Clozapine / Q000009:adverse effects; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D004829:Epilepsy, Generalized / Q000139:chemically induced; D005260:Female; D006801:Humans; D018967:Risperidone / Q000627:therapeutic use; D012560:Schizophrenia, Catatonic / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology / Q000628:therapy; D012561:Schizophrenia, Childhood / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D012565:Schizophrenic Psychology
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; D000078306:Clobazam; D003024:Clozapine; D018967:Risperidone